Benjamin Looker - 20 Jan 2026 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
General Counsel
Signature
/s/ Sheldon L. Koenig, by power of attorney
Issuer symbol
ESPR
Transactions as of
20 Jan 2026
Net transactions value
-$4,868
Form type
4
Filing time
21 Jan 2026, 17:17:27 UTC
Previous filing
18 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Looker Benjamin General Counsel C/O ESPERION THERAPEUTICS, INC., 3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR /s/ Sheldon L. Koenig, by power of attorney 21 Jan 2026 0001859509

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale $4,868 -1,689 -0.44% $2.88 384,216 20 Jan 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on vested shares of restricted stock units.